Skip to content

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis (PsOsim)

This 3-part study will compare the efficacy and safety of adalimumab biosimilar CHS-1420 versus Humira in subjects with chronic plaque psoriasis. The PsOsim Study is a double-blind, randomized, parallel-group, active-control study to compare the efficacy and safety of CHS-1420 versus Humira in subjects with chronic plaque psoriasis. It is not infectious, therefore you cannot catch custom essay papers writing service psoriasis from someone else. Comparison of CHS-1420 Versus essay writing service cheap Humira in Subjects With Chronic Plaque Psoriasis (PsOsim).

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis (PsOsim) 2

A Double-blind, Randomized, Parallel-group, Active-control Study To Compare The Efficacy And Safety Of Chs-1420 Versus Humira In Subjects With Chronic Plaque Psoriasis

This is a 3-part study comparing CHS-1420 to Humira in patients with chronic plaque psoriasis 3

A Double-blind, Randomized, Parallel-group, Active-control Study To Compare The Efficacy And Safety Of Chs-1420 Versus Humira In Subjects With Chronic Plaque Psoriasis